1. Home
  2. PGEN vs XYF Comparison

PGEN vs XYF Comparison

Compare PGEN & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.84

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo X Financial each representing six

XYF

X Financial each representing six

HOLD

Current Price

$5.53

Market Cap

207.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
XYF
Founded
1998
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
207.6M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
PGEN
XYF
Price
$6.84
$5.53
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$8.33
N/A
AVG Volume (30 Days)
4.6M
69.7K
Earning Date
05-13-2026
05-18-2026
Dividend Yield
N/A
11.34%
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
N/A
Revenue Next Year
$81.04
N/A
P/E Ratio
$229.00
$0.90
Revenue Growth
N/A
N/A
52 Week Low
$2.99
$3.30
52 Week High
$7.72
$15.58

Technical Indicators

Market Signals
Indicator
PGEN
XYF
Relative Strength Index (RSI) 51.21 55.72
Support Level $6.60 $5.44
Resistance Level $7.32 $5.65
Average True Range (ATR) 0.31 0.29
MACD -0.09 -0.02
Stochastic Oscillator 18.27 59.38

Price Performance

Historical Comparison
PGEN
XYF

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.

Share on Social Networks: